Cmp Pharma Inc Company Profile
What is the competitive landscape for CMP PHARMA INC
CMP PHARMA INC has three approved drugs.
Drugs and US Patents for Cmp Pharma Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cmp Pharma Inc | SODIUM POLYSTYRENE SULFONATE | sodium polystyrene sulfonate | POWDER;ORAL, RECTAL | 089910-001 | Jan 19, 1989 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Cmp Pharma Inc | ISONIAZID | isoniazid | SYRUP;ORAL | 088235-001 | Nov 10, 1983 | AA | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| Cmp Pharma Inc | SPS | sodium polystyrene sulfonate | SUSPENSION;ORAL, RECTAL | 087859-001 | Dec 8, 1982 | AA | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

